Abstract
Risk of CNS Relapse with Diffuse Large B-Cell Lymphoma (DLBCL) in the Rituximab Era: Results from the UK NCRI R-CHOP 14 v 21 Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1182/blood.v124.21.1723.1723
Copy DOIJournal: Blood | Publication Date: Dec 6, 2014 |
Citations: 1 |
Risk of CNS Relapse with Diffuse Large B-Cell Lymphoma (DLBCL) in the Rituximab Era: Results from the UK NCRI R-CHOP 14 v 21 Trial
Join us for a 30 min session where you can share your feedback and ask us any queries you have